Clinical Trial Update: A Study in Second Line Metastatic Colorectal Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial in second-line metastatic colorectal cancer has completed with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Eli Lilly and Company | Conditions: Colorectal Cancer | Phase 3 | Status: COMPLETED | Results posted: 2015-07-15